New York Oncology Hematology, P.C.
Amsterdam, New York 12010
at this facility
Prostate Cancer Clinical Trial
An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate CancerStatus: Enrolling, Phase II
Click here to add this to my saved trials